AdAlta has raised $2.5 million from sophisticated investors to accelerate development of its lead CAR T therapy, BZDS1901, and to progress manufacturing and regulatory milestones in Australia and the United States. …
AdAlta secures funds to advance CAR-T therapy after positive clinical responses
May 4, 2026 Australian Biotech
Latest Video
New Stories
-
The risk to patients of this institution getting too close to the sun
May 25, 2026 - - Latest News -
Pharmacy Guild urges immediate funding for pharmacy to vaccinate in response to outbreak
May 24, 2026 - - Latest News -
AusBiotech launches survey in response to Budget’s 'blind spot' on R&D impact
May 24, 2026 - - Australian Biotech -
Like rearranging deck chairs on the Titanic. The ship is still going to sink
May 23, 2026 - - Latest News -
Merck funds Indigenous STEM leaders at Macquarie University
May 22, 2026 - - Latest News -
The sharper language will need to be accompanied by even sharper actions
May 22, 2026 - - Latest News -
Industry chiefs want united front as agreement negotiations get underway
May 22, 2026 - - Latest News